Jump to content

[Animals] Study: Sea anemones may fight Alzheimer's


Recommended Posts

Russian scientists said that sea anemones contain chemical compounds that can slow down the inflammatory process and deterioration of neurons, which cause the development of Alzheimer's disease.


السمكة المهرج و علاقتها التكافلية مع شقائق النعمان



This came in a study conducted by researchers at the Eastern Federal University in Russia, and published its results in the latest issue of the "Russian Journal of Bioorganic Chemistry".

Anemones are poisonous mollusk marine animals with a flower-like shape, and they have many poisonous tentacles, and they live at depths not exceeding 50 meters below the surface of the water, and they live in warm waters, and the age of these animals can reach nearly 50 years.

The researchers explained that sea anemones contain "peptides", which are chemical compounds consisting of amino acids with high physiological activity, allowing them to regulate various biological processes.

The team collected anemones near the Seychelles Islands in Africa during a scientific marine expedition, and extracted a group of peptides from them, and conducted research in the laboratory on a group of neurons of mice, and found that the peptides extracted from anemones contain therapeutic properties that prevent the destruction and deterioration of neurons by stopping The development of infections.

The team pointed out that Alzheimer's patients usually suffer from various neurological disorders, including confusion and memory loss, so the peptides were tested on neuroblastoma cells of mice, and they found that they succeeded in reducing neuronal damage.

Additional studies
Lead researcher Dr. Elena Leshchenko said that sea anemones contain a wide range of biological substances that not only have neuroprotective properties, but also have anti-cancer properties.

However, she explained that these biological compounds require additional studies, as it is not possible to start manufacturing new drugs from them until after completing all stages of scientific experiments, before reaching clinical trials in humans, and this will take from three to five years.

It is noteworthy that Alzheimer's disease is the most common form of dementia, and it leads to a continuous deterioration in thinking abilities, brain functions and memory loss. The disease develops gradually to the loss of the ability to do daily work and to communicate with the environment, and the situation may deteriorate to the point of lack of functional performance.

According to the American Alzheimer's Association report for 2016, the disease affects about 47 million people around the world, and costs health care systems in the world more than $ 818 billion.




Link to comment
Share on other sites

  • SnO locked this topic
This topic is now closed to further replies.
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.